Related Experiment Video
Updated: Jun 1, 2026

Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
Gene therapy development for retinal diseases
Felix F L Reichel1, Julia-Sophia Bellingrath2, Peter Kiraly3
1University Eye Hospital, Centre for Ophthalmology, University Hospital Tübingen, Tübingen, Germany.
Abstract:
Gene therapy is being investigated as a potential treatment for a range of inherited and acquired retinal diseases. This chapter provides an overview of current gene therapy strategies, including gene augmentation and gene editing approaches. Techniques targeting both DNA and RNA are discussed, along with considerations for the use of viral and nonviral delivery systems. Challenges such as accurate gene identification, vector optimization, immune responses, and the availability of representative disease models are discussed in detail. Clinical applications are explored in the context of inherited retinal dystrophies, including recent trial outcomes and morphologic and functional endpoints. Overall, the chapter outlines the current state of research and development in retinal gene therapy and summarizes key considerations for clinical translation.
More Related Videos
07:43Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Tissue in a Feline Large Animal Model
Published on: August 5, 2021
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
Related Concept Videos
Gene Therapy
Gene Therapy
iPS Cell Differentiation